- Home
- BCBP vs CRVS Comparison
BCBP vs CRVS Comparison
Compare BCBP & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCBP | CRVS |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.0M | 546.7M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | BCBP | CRVS |
|---|---|---|
| Price | $7.89 | $25.11 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $9.25 | ★ $28.00 |
| AVG Volume (30 Days) | 85.1K | ★ 6.7M |
| Earning Date | 01-28-2026 | 11-04-2025 |
| Dividend Yield | ★ 8.02% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $64,592,000.00 | N/A |
| Revenue This Year | $23.06 | N/A |
| Revenue Next Year | $3.55 | N/A |
| P/E Ratio | $160.33 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.41 | $2.54 |
| 52 Week High | $12.26 | $26.22 |
Technical Indicators
Market Signals| Indicator | BCBP | CRVS |
|---|---|---|
| Relative Strength Index (RSI) | 45.71 | 91.48 |
| Support Level | $7.54 | $6.46 |
| Resistance Level | $8.02 | $7.18 |
| Average True Range (ATR) | 0.18 | 1.66 |
| MACD | -0.01 | 2.20 |
| Stochastic Oscillator | 53.03 | 91.63 |
Price Performance
Historical ComparisonAbout BCBP BCB Bancorp Inc. (NJ)
BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).